Exact Mass: 451.14680760000005

Exact Mass Matches: 451.14680760000005

Found 457 metabolites which its exact mass value is equals to given mass value 451.14680760000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Doxazosin

1 (4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine

C23H25N5O5 (451.18556)

Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic α₁-adrenergic receptors. It may be used to mild to moderate hypertension and in the management of symptomatic benign prostatic hyperplasia (BPH). α₁-Receptors mediate contraction and hypertrophic growth of smooth muscle cells. Antagonism of these receptors leads to smooth muscle relaxation in the peripheral vasculature and prostate gland. C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Flucythrinate

Benzeneacetic acid,4-(difluoromethoxy)-a-(1-methylethyl)-, cyano(3-phenoxyphenyl)methyl ester

C26H23F2NO4 (451.1595062)

(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[(1R,2R)-1-hydroxy-1,2-dihydronaphthalen-2-yl]sulfanyl}ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C20H25N3O7S (451.141314)

This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.

(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[(1R,2R)-2-hydroxy-1,2-dihydronaphthalen-1-yl]sulfanyl}ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C20H25N3O7S (451.141314)

(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[(1S,2S)-1-hydroxy-1,2-dihydronaphthalen-2-yl]sulfanyl}ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C20H25N3O7S (451.141314)

4-Phenylbutyl glucosinolate

{[(e)-(5-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}pentylidene)amino]oxy}sulphonic acid

C17H25NO9S2 (451.097068)

4-Phenylbutyl glucosinolate is found in brassicas. 4-Phenylbutyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 4-Phenylbutyl glucosinolate is found in horseradish and brassicas.

5-O-Feruloylnigrumin

(2Z)-2-cyano-2-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethylidene)ethyl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C21H25NO10 (451.147839)

5-O-Feruloylnigrumin is found in fruits. 5-O-Feruloylnigrumin is a constituent of the seeds of Ribes nigrum (blackcurrant). Constituent of the seeds of Ribes nigrum (blackcurrant). 5-O-Feruloylnigrumin is found in fruits.

4-Amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-hydroxybenzamide

4-Amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-hydroxybenzene-1-carboximidate

C22H27ClFN3O4 (451.16740240000007)

4-Hydroxypropranolol glucuronide

3,4,5-trihydroxy-6-[(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}naphthalen-1-yl)oxy]oxane-2-carboxylic acid

C22H29NO9 (451.18422240000007)

Betrixaban

N-(5-chloropyridin-2-yl)-2-[4-(N,N-dimethylcarbamimidoyl)benzamido]-5-methoxybenzamide

C23H22ClN5O3 (451.1411092000001)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins

4H-Pyrido(4',3':4,5)thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 7,8,9,10-tetrahydro-6-(2-chlorophenyl)-9-(cyclopropylcarbonyl)-1,4-dimethyl-, (S)-

9-(2-chlorophenyl)-14-cyclopropanecarbonyl-3,7-dimethyl-17-thia-2,4,5,8,14-pentaazatetracyclo[8.7.0.0^{2,6}.0^{11,16}]heptadeca-1(10),3,5,8,11(16)-pentaene

C23H22ClN5OS (451.12335120000006)

Rigosertib

2-[(2-methoxy-5-{[2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}phenyl)amino]acetic acid

C21H25NO8S (451.130081)

Succinyl-trialanine-4-nitroanilide

3-[(1-{[1-({1-[(4-nitrophenyl)carbamoyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-C-hydroxycarbonimidoyl]propanoate

C19H25N5O8 (451.170305)

D-Phenylalanine, 4-fluoro-N-(((5-(4-fluorophenyl)-2-benzofuranyl)methoxy)carbonyl)-

3-(4-Fluorophenyl)-2-[({[5-(4-fluorophenyl)-1-benzofuran-2-yl]methoxy}(hydroxy)methylidene)amino]propanoate

C25H19F2NO5 (451.12312280000003)

(2S)-2-((3-((4-(4-Fluorophenoxy)phenyl)methylcarbamoyl)-4-methoxy-phenyl)methyl)butanoic acid

2-{[3-({[4-(4-fluorophenoxy)phenyl]methyl}-C-hydroxycarbonimidoyl)-4-methoxyphenyl]methyl}butanoate

C26H26FNO5 (451.17949180000005)

(4E)-5-{6-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-beta-glucopyranosylsulfanyl}pent-4-enenitrile

C21H25NO8S (451.130081)

Uvarindole D

C29H25NO4 (451.178349)

(1S,4R)-1-(beta-D-Glucopyranosyloxy)-4-(6-deoxy-beta-D-gulopyranosyloxy)-2-cyclopentene-1-carboxamide

C18H29NO12 (451.16896740000004)

doxazosin

Doxazosin, (R)-

C23H25N5O5 (451.18556)

C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3293

Ala Cys Cys Arg

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C15H29N7O5S2 (451.1671504)

Ala Cys Lys Met

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923008)

Ala Cys Met Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C17H33N5O5S2 (451.1923008)

Ala Cys Met Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C16H29N5O6S2 (451.1559174)

Ala Cys Gln Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O6S2 (451.1559174)

Ala Cys Arg Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1671504)

Ala Lys Cys Met

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923008)

Ala Lys Met Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923008)

Ala Met Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]hexanoic acid

C17H33N5O5S2 (451.1923008)

Ala Met Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C16H29N5O6S2 (451.1559174)

Ala Met Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923008)

Ala Met Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C16H29N5O6S2 (451.1559174)

Ala Gln Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O6S2 (451.1559174)

Ala Gln Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C16H29N5O6S2 (451.1559174)

Ala Arg Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1671504)

Cys Ala Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C15H29N7O5S2 (451.1671504)

Cys Ala Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923008)

Cys Ala Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C17H33N5O5S2 (451.1923008)

Cys Ala Met Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C16H29N5O6S2 (451.1559174)

Cys Ala Gln Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O6S2 (451.1559174)

Cys Ala Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1671504)

Cys Cys Ala Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanamido]-5-carbamimidamidopentanoic acid

C15H29N7O5S2 (451.1671504)

Cys Cys Ile Asn

(2S)-2-[(2S,3S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylpentanamido]-3-carbamoylpropanoic acid

C16H29N5O6S2 (451.1559174)

Cys Cys Lys Val

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]-3-methylbutanoic acid

C17H33N5O5S2 (451.1923008)

Cys Cys Leu Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-methylpentanamido]-3-carbamoylpropanoic acid

C16H29N5O6S2 (451.1559174)

Cys Cys Asn Ile

(2S,3S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-methylpentanoic acid

C16H29N5O6S2 (451.1559174)

Cys Cys Asn Leu

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-methylpentanoic acid

C16H29N5O6S2 (451.1559174)

Cys Cys Gln Val

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-methylbutanoic acid

C16H29N5O6S2 (451.1559174)

Cys Cys Arg Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]propanoic acid

C15H29N7O5S2 (451.1671504)

Cys Cys Val Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]hexanoic acid

C17H33N5O5S2 (451.1923008)

Cys Cys Val Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-4-carbamoylbutanoic acid

C16H29N5O6S2 (451.1559174)

Cys Asp Lys Ser

(3S)-3-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pentyl]carbamoyl}-3-[(2R)-2-amino-3-sulfanylpropanamido]propanoic acid